Navigation Links
FRC's Jeanne Monahan Testifies Before House Judiciary Committee, Urges Repeal of Discriminatory Mandate
Date:2/28/2012

WASHINGTON, Feb. 28, 2012 /PRNewswire-USNewswire/ -- Today, Jeanne Monahan, director of the Family Research Council's (FRC) Center for Human Dignity, testified before the House Judiciary Committee regarding the Obama administration's contraceptive mandate at the hearing titled "Executive Overreach: The HHS [Department of Health and Human Services] Mandate Versus Religious Liberty." The following are excerpts from her testimony:

(Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO)

"In a letter to the President and members of Congress recently signed by thousands of women of 18 different faiths and representing doctors, nurses, lawyers, teachers, mothers, community care workers, business owners, scholars and more women voiced their ardent opposition to the mandate. The letter included these observations: 'We listened to prominent women purport to speak for us. We watched them duck the fundamental religious-liberty issues at stake. No one speaks for all women on these issues. Those who purport to do so are simply attempting to deflect attention from the serious religious liberty issues at stake. We call on President Obama, Health and Human Services Secretary Kathleen Sebelius, and our representatives in Congress to respect religious voices, to respect religious liberty, and to allow religious institutions and individuals to continue to provide witness to their faiths in all their fullness.'

"The contraceptive mandate is an unprecedented directive which deeply conflicts with religious and conscience freedom protections the American people currently receive. In our democratic society governed by the U.S. Constitution, it is not the role of this Administration to dictate what does or does not violate another person's conscience on matters as critical as life and death. It is the job of the government to defend those rights, not trample them.

"This Administration's act of discrimination against people of faith, and women of faith, must be stopped. As C.S. Lewis said, you can be sincere, and sincerely wrong. We don't question the President's motives, but we think he is wrong. You may disagree with me, and think that I and the thousands of women like me are wrong. Fine, but do not discriminate against us and force us to violate our consciences. We urge you not to allow this President to discriminate against those with moral or religious objections to this mandate coverage of contraceptives, sterilization services, and abortifacients."

To read her full testimony, click here: http://www.frc.org/testimony/testimony-of-jeanne-monahan-before-us-house-judiciary-committee

Click here to read Ms. Monahan's U.S. News & World Report op-ed on the contraceptive mandate: http://www.usnews.com/debate-club/should-catholic-and-other-religious-institutions-have-to-cover-birth-control/the-uproar-over-obamas-choice-has-to-do-with-more-than-contraception


'/>"/>
SOURCE Family Research Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Pharmacy Leader Jeanne Ann Stasny Joins Diplomat Specialty Pharmacy as Vice President of Pharmacy Services
2. FRCs Jeanne Monahan Responds to Two New Deaths from RU-486
3. Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
4. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
5. Homecare Provider Testifies on Downside of Medicare Competitive Bidding Program Before House Energy and Commerce Subcommittee
6. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
7. AVMA Testifies in Support of Judicious Use of Antimicrobials in Food Animals
8. FDA CONSUMER HEALTH INFORMATION - Know Concentration Before Giving Acetaminophen to Infants
9. Retail Pharmacy Teams Help Patients Maximize FSA Funds Before Year End
10. Successful ILM-Blue Patent Opposition Proceedings Before the European Patent Office; Patent Validity Confirmed
11. Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CLEVELAND , Jan. 18, 2017  ViewRay, ... the world,s first and only clinical MRI-guided radiation ... gross proceeds of approximately $26.1 million through a ... Puissance Capital Management led the financing and was ... OrbiMed Advisors, LLC and Kearny Venture Partners, and ...
(Date:1/19/2017)... 18, 2017 The Academy of Managed ... Administration (FDA) for its release today of draft ... decision makers can proactively share clinical and economic ... as emerging therapies awaiting FDA approval. ... that AMCP developed during two multi-stakeholder meetings last ...
(Date:1/18/2017)... 2017 Research and Markets has announced the addition ... User - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to ... Vital signs ... to reach $5,491 million by 2022, growing at a CAGR of 5.8% ... was the leading regional market in global vital signs monitoring devices ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Students interested in video can get a jump start on ... earn a $1,000 scholarship and have his or her video posted on the GenCure ... May 31, with the winner announced on June 9. , The competition is designed ...
(Date:1/19/2017)... PA (PRWEB) , ... January 19, 2017 , ... Allegheny ... experience of patients who seek access to the Network’s programs and services in the ... primary or specialty care appointments will be offered one for that same afternoon. ...
(Date:1/19/2017)... ... January 19, 2017 , ... For ... serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity ... (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, is ...
(Date:1/19/2017)... ... 2017 , ... For the second consecutive year, all five ... have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, Dr. Joshua ... by their peers for the 2017 list based on their exceptional patient care ...
(Date:1/19/2017)... ... , ... The 21st Century Cures Act’s Impact on Medical Devices:, What You ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do ... this year? , The passage of the act means devicemakers will be scrambling to ...
Breaking Medicine News(10 mins):